ReviewEye (London, England)2025
Non-human primates as preclinical models for optic nerve research: advancing insights into their application and potential.
Review in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Initial assessment of a species-specific rebound measurement mode for non-human primates.BMC veterinary research · 2026Article
- Integrative Landscape of Dry AMD Pathogenesis, Models, and Emerging Therapeutic Strategies.International journal of molecular sciences · 2025Review
- Multifunctional nanoplatforms for optic nerve regeneration integrating anti-inflammatory, epigenetic, and ionic mechanisms with emerging artificial intelligence technologies.Cell biology and toxicology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Optic neuropathies are a group of disorders characterized by damage or dysfunction of the optic nerve, which transmits visual information from the retina to the brain. Common causes include glaucoma, ischemic optic neuropathy, optic neuritis, hereditary optic neuropathies and traumatic or compressive optic neuropathies. These conditions can result in vision loss, decreased visual acuity, color vision defects, and visual field abnormalities. The effective treatment strategies have been urgently addressed for long. Consequently, development of both spontaneous and experimental disease models is crucial to thoroughly illustrate disease property and biological mechanisms. As the largest ocular study conducted in non-human primates (NHPs), NHP eye study (NHPES) provided a comprehensive insight into optic nerve survey by launching normal range of relevant parameters and some spontaneous optic nerve disorders, laying the foundation for translation from monkey models to human clinical applications. NHPs are the most ideal animal models because of the marked species proximity through evolution between them and human, so substantial efforts have been attempted toward establishing NHP models for optic nerve research. These animals are of great importance for accelerating the exploitation of novel treatment targets, promoting advantageous drug delivery methods and enhancing patients' outcomes. Furthermore, the sophisticated structure and physiological function of monkeys faithfully replicate the typical pathology and progression of specific diseases. In the current narrative review, we provide an overview of why NHPs could be used to study the optic nerve and the significance of NHPES compared with other eye studies of monkeys.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.